FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION PRALIDOXIME CHLORIDE (AUTOINJECTOR) (PRALIDOXIME CHLORIDE) SOLUTION, 600 MILLIGRAMS/2 MILLILITERS (300 MILLIGRAMS/MILLILITER), WAS NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Oct. 6 -- Food and Drug Administration has issued a notice called: Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness.

The notice was published in the Federal Register on Oct. 6 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, Agency, or we) has determined that PRALIDOXIME CHLORIDE (AUTOINJECTOR) (pralidoxime chloride) solution, 600 milligrams (mg)/2 milliliters (mL) (300 mg/mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to ...